• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Transcutaneous Carbon Dioxide Treatment Is Capable of Reducing Peripheral Vascular Resistance in Hypertensive Patients.经皮二氧化碳治疗能够降低高血压患者的外周血管阻力。
In Vivo. 2018 Nov-Dec;32(6):1555-1559. doi: 10.21873/invivo.11414.
2
Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.阿托伐他汀小剂量对高血压合并高脂血症患者动脉僵硬度和中心动脉压增强的影响。
Am J Hypertens. 2013 May;26(5):608-16. doi: 10.1093/ajh/hps098. Epub 2013 Feb 28.
3
Aortic Stiffness, Ambulatory Blood Pressure, and Predictors of Response to Antihypertensive Therapy in Hemodialysis.血液透析患者的主动脉僵硬度、动态血压与降压治疗反应的预测因素。
Am J Kidney Dis. 2015 Aug;66(2):305-12. doi: 10.1053/j.ajkd.2015.01.018. Epub 2015 Mar 25.
4
Is Arterial Hypertension Control Enough to Improve Aortic Stiffness in Untreated Patients With Hypertension? A 3-Year Follow-Up Study.单纯高血压未治疗患者的动脉高血压控制足以改善主动脉僵硬度吗?一项3年随访研究。
Angiology. 2015 Sep;66(8):759-65. doi: 10.1177/0003319714552811. Epub 2014 Sep 30.
5
Beneficial effects of low-dose aspirin on aortic stiffness in hypertensive patients.小剂量阿司匹林对高血压患者主动脉僵硬度的有益影响。
Vasc Med. 2014 Dec;19(6):452-7. doi: 10.1177/1358863X14556695. Epub 2014 Oct 31.
6
Acute hypertensive response in ischemic stroke is associated with increased aortic stiffness.缺血性卒中急性高血压反应与主动脉僵硬度增加有关。
Atherosclerosis. 2016 Aug;251:1-5. doi: 10.1016/j.atherosclerosis.2016.04.027. Epub 2016 May 7.
7
Volume status and arterial blood pressures are associated with arterial stiffness in hemodialysis patients.容量状态和动脉血压与血液透析患者的动脉僵硬度相关。
Int J Artif Organs. 2018 Jul;41(7):378-384. doi: 10.1177/0391398818778212. Epub 2018 May 28.
8
Aortic-Brachial Pulse Wave Velocity Ratio: A Blood Pressure-Independent Index of Vascular Aging.主动脉-肱动脉脉搏波速度比值:一个与血压无关的血管老化指标。
Hypertension. 2017 Jan;69(1):96-101. doi: 10.1161/HYPERTENSIONAHA.116.08409. Epub 2016 Nov 7.
9
Beneficial effect of vardenafil on aortic stiffness and wave reflections.伐地那非对主动脉僵硬度和波反射的有益作用。
J Clin Pharmacol. 2012 Aug;52(8):1215-21. doi: 10.1177/0091270011413586. Epub 2011 Sep 27.
10
Early intervention of long-acting nifedipine GITS reduces brachial-ankle pulse wave velocity and improves arterial stiffness in Chinese patients with mild hypertension: a 24-week, single-arm, open-label, prospective study.长效硝苯地平控释片早期干预可降低中国轻度高血压患者的臂踝脉搏波速度并改善动脉僵硬度:一项为期24周的单臂、开放标签、前瞻性研究。
Drug Des Devel Ther. 2016 Oct 18;10:3399-3406. doi: 10.2147/DDDT.S117221. eCollection 2016.

引用本文的文献

1
Carbon dioxide and MAPK signalling: towards therapy for inflammation.二氧化碳与 MAPK 信号转导:炎症治疗的新靶点
Cell Commun Signal. 2023 Oct 10;21(1):280. doi: 10.1186/s12964-023-01306-x.
2
The Tissue Response to Hypoxia: How Therapeutic Carbon Dioxide Moves the Response toward Homeostasis and Away from Instability.缺氧组织反应:治疗性二氧化碳如何使反应向体内平衡移动并远离不稳定性。
Int J Mol Sci. 2023 Mar 8;24(6):5181. doi: 10.3390/ijms24065181.
3
The effect of transcutaneous application of gaseous CO on diabetic chronic wound healing-A double-blind randomized clinical trial.气态 CO 经皮给药对糖尿病慢性伤口愈合的影响:一项双盲随机临床试验。
Int Wound J. 2020 Dec;17(6):1607-1614. doi: 10.1111/iwj.13436. Epub 2020 Jul 7.

本文引用的文献

1
Transcutaneous carbon dioxide application with hydrogel prevents muscle atrophy in a rat sciatic nerve crush model.水凝胶经皮应用二氧化碳可预防大鼠坐骨神经挤压模型中的肌肉萎缩。
J Orthop Res. 2018 Jun;36(6):1653-1658. doi: 10.1002/jor.23817. Epub 2017 Dec 19.
2
Angiotensin-converting Enzyme Inhibition Improves the Effectiveness of Transcutaneous Carbon Dioxide Treatment.血管紧张素转换酶抑制可提高经皮二氧化碳治疗的有效性。
In Vivo. 2017 May-Jun;31(3):425-428. doi: 10.21873/invivo.11077.
3
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society.血管生物标志物在一级和二级预防中的作用。欧洲心脏病学会外周循环工作组的立场文件:得到动脉结构和生理学研究协会(ARTERY 协会)的认可。
Atherosclerosis. 2015 Aug;241(2):507-32. doi: 10.1016/j.atherosclerosis.2015.05.007. Epub 2015 May 16.
4
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2013年欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理指南:欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理特别工作组
J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc.
5
Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts.使用 SCORE、Framingham 和 ESH/ESC 风险图表的脉搏波速度、尿白蛋白肌酐比和左心室质量指数的阈值。
J Hypertens. 2012 Oct;30(10):1928-36. doi: 10.1097/HJH.0b013e328356c579.
6
Type 2 diabetes is associated with increased pulse wave velocity measured at different sites of the arterial system but not augmentation index in a Chinese population.2 型糖尿病与中国人群动脉系统不同部位测量的脉搏波速度增加有关,但与增强指数无关。
Clin Cardiol. 2011 Oct;34(10):622-7. doi: 10.1002/clc.20956.
7
A novel system for transcutaneous application of carbon dioxide causing an "artificial Bohr effect" in the human body.一种新型的二氧化碳经皮应用系统,可在人体中产生“人工波尔效应”。
PLoS One. 2011;6(9):e24137. doi: 10.1371/journal.pone.0024137. Epub 2011 Sep 8.
8
Pharmacological modulation of arterial stiffness.动脉僵硬度的药理学调节。
Drugs. 2011 Sep 10;71(13):1689-701. doi: 10.2165/11593790-000000000-00000.
9
Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity.新的振荡测量设备(Arteriograph)测量增强指数、中心血压和主动脉脉搏波速度的侵袭性验证。
J Hypertens. 2010 Oct;28(10):2068-75. doi: 10.1097/HJH.0b013e32833c8a1a.
10
Combination therapy of calcium channel blocker and angiotensin II receptor blocker reduces augmentation index in hypertensive patients.钙通道阻滞剂和血管紧张素 II 受体阻滞剂联合治疗可降低高血压患者的增强指数。
Am J Med Sci. 2010 May;339(5):433-9. doi: 10.1097/MAJ.0b013e3181d658c4.

经皮二氧化碳治疗能够降低高血压患者的外周血管阻力。

Transcutaneous Carbon Dioxide Treatment Is Capable of Reducing Peripheral Vascular Resistance in Hypertensive Patients.

作者信息

Németh Balázs, Kiss István, Ajtay Bella, Péter Iván, Kreska Zita, Cziráki Attila, Horváth Iván G, Ajtay Zénó

机构信息

Department of Public Health Medicine, Medical School, University of Pécs, Pécs, Hungary

Zsigmondy Vilmos SPA Hospital, Harkány, Hungary.

出版信息

In Vivo. 2018 Nov-Dec;32(6):1555-1559. doi: 10.21873/invivo.11414.

DOI:10.21873/invivo.11414
PMID:30348716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6365751/
Abstract

AIM

We aimed to investigate the effects of a single carbon dioxide (CO) treatment on arterial stiffness by monitoring the changes of aortic pulse-wave velocity (PWV) and aortic augmentation index (AIXao), which are indicators of arterial stiffness.

PATIENTS AND METHODS

PWV and AIXao were measured by an invasively validated oscillometric device. The measurements of stiffness parameters were performed before the CO treatment, and at 1, 4 and 8 h after the first treatment.

RESULTS

Thirty-one patients were included. No significant changes were found in PWV. AIXao decreased significantly 1 h and 4 h after CO treatment compared to baseline values (p=0.034 and p<0.001). AIXao increased 8 h after the CO treatment, but remained significantly lower than baseline AIXao values (p=0.016).

CONCLUSION

CO treatment is capable of reducing peripheral vascular resistance. We hypothesize that CO is not only a temporal vasodilator but is also capable of activating vasodilation pathways.

摘要

目的

我们旨在通过监测主动脉脉搏波速度(PWV)和主动脉增强指数(AIXao)的变化来研究单次二氧化碳(CO)治疗对动脉僵硬度的影响,这两个指标是动脉僵硬度的指标。

患者和方法

PWV和AIXao通过经侵入性验证的示波装置进行测量。在CO治疗前以及首次治疗后1、4和8小时进行僵硬度参数的测量。

结果

纳入31例患者。PWV未发现显著变化。与基线值相比,CO治疗后1小时和4小时AIXao显著降低(p = 0.034和p < 0.001)。CO治疗后8小时AIXao升高,但仍显著低于基线AIXao值(p = 0.016)。

结论

CO治疗能够降低外周血管阻力。我们推测CO不仅是一种短效血管扩张剂,还能够激活血管舒张途径。